carvedilol has been researched along with Canine Diseases in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Demographic, physical examination and diagnostic imaging findings, blood pressure (BP), administration details and outcome were obtained from medical records of dogs receiving carvedilol for preclinical CVD." | 3.78 | Retrospective review of carvedilol administration in 38 dogs with preclinical chronic valvular heart disease. ( Boggess, MM; Gordon, SG; Hariu, CD; Miller, MW; Saunders, AB, 2012) |
| " Thus, it is necessary to titrate the dosage of carvedilol, it should be initiated at less than 0." | 1.31 | Cardiovascular and renal effects of carvedilol in dogs with heart failure. ( Ishikawa, Y; Sasaki, T; Uechi, M; Ueno, K; Yamamoto, T, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duckett, MM | 1 |
| Phung, SK | 1 |
| Nguyen, L | 1 |
| Khammanivong, A | 1 |
| Dickerson, E | 1 |
| Dusenbery, K | 1 |
| Lawrence, J | 1 |
| Pino, EHM | 1 |
| Weber, MN | 1 |
| de Oliveira, LO | 1 |
| Vieira, LC | 1 |
| Dos Santos, KHS | 1 |
| Liu, IP | 1 |
| Gomes, HM | 1 |
| Trindade-Gerardi, AB | 1 |
| Moreira, JCF | 1 |
| Gerardi, DG | 1 |
| Gordon, SG | 1 |
| Saunders, AB | 1 |
| Hariu, CD | 1 |
| Boggess, MM | 1 |
| Miller, MW | 1 |
| Kang, MH | 1 |
| Park, HM | 1 |
| Uechi, M | 1 |
| Sasaki, T | 1 |
| Ueno, K | 1 |
| Yamamoto, T | 1 |
| Ishikawa, Y | 1 |
1 trial available for carvedilol and Canine Diseases
| Article | Year |
|---|---|
Evaluation of cardioprotective effects of carvedilol in dogs receiving doxorubicin chemotherapy: A prospective, randomized, double-blind, placebo controlled pilot study.
Topics: Animals; Antibiotics, Antineoplastic; Cardiotonic Agents; Carvedilol; Diastole; Dog Diseases; Dogs; | 2021 |
4 other studies available for carvedilol and Canine Diseases
| Article | Year |
|---|---|
The adrenergic receptor antagonists propranolol and carvedilol decrease bone sarcoma cell viability and sustained carvedilol reduces clonogenic survival and increases radiosensitivity in canine osteosarcoma cells.
Topics: Adrenergic beta-Antagonists; Animals; Bone Neoplasms; Carvedilol; Cell Line, Tumor; Dog Diseases; Do | 2020 |
Retrospective review of carvedilol administration in 38 dogs with preclinical chronic valvular heart disease.
Topics: Adrenergic beta-Antagonists; Aging; Animals; Carbazoles; Carvedilol; Chronic Disease; Dog Diseases; | 2012 |
Application of carvedilol in a dog with pseudoephedrine toxicosis-induced tachycardia.
Topics: Acepromazine; Animals; Carbazoles; Carvedilol; Cetirizine; Dog Diseases; Dogs; Female; Nasal Deconge | 2012 |
Cardiovascular and renal effects of carvedilol in dogs with heart failure.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agoni | 2002 |